Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother

Hypertension

Volumn 53, Issue 6, 2009, Pages 944-951

  Lykke, Jacob A ^a,b,c   Langhoff Roos, Jens ^a   Sibai, Baha M ^d   Funai, Edmund F ^b   Triche, Elizabeth W ^b   Paidas, Michael J ^b  

^a Rigshospitalet   (Denmark)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Diabetes mellitus; Epidemiology; Ischemia; Preeclampsia; Pregnancy; Stroke; Vascular diseases

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DENMARK; FEMALE; GESTATIONAL AGE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MATERNAL DIABETES MELLITUS; MATERNAL HYPERTENSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PARITY; PREECLAMPSIA; PREMATURE LABOR; PRIMIGRAVIDA; PRIORITY JOURNAL; RECURRENT DISEASE; SOLUTIO PLACENTAE; STILLBIRTH; STROKE; THROMBOEMBOLISM; CASE CONTROL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; HIGH RISK PREGNANCY; HOSPITALIZATION; INCIDENCE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; PREMATURITY; PROBABILITY; PROPORTIONAL HAZARDS MODEL; REGISTER;

ADULT; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COHORT STUDIES; DENMARK; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INCIDENCE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY RATE; PREGNANCY, HIGH-RISK; PREMATURE BIRTH; PROBABILITY; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 67049118952     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.130765     Document Type: Article

References (42)

1. Bai J, Wong FWS, Bauman A, Mohsin M. Parity and pregnancy outcomes. Am J Obstet Gynecol. 2002;186:274-278.
2. Ness RB, Sibai BM. Shared and disparate components of the pathophys-iologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol. 2006;195:40-49.
3. Redman CW. Immunology of preeclampsia. Semin Perinatal. 1991;15: 257-262.
4. Pabinger I, Vormittag R. Thrombophilia and pregnancy outcomes. J Thromb Haemost. 2005;3:1603-1610.
5. Sankaralingam S, Arenas IA, Lalu MM, Davidge ST. Preeclampsia: current understanding of the molecular basis of vascular dysfunction. Expert Rev Mol Med. 2006;8:1-20.
6. Lindheimer MD, Romero R. Emerging roles of antiangiogenic and angiogenic proteins in pathogenesis and prediction of preeclampsia. Hypertension. 2007;50:35-36.
7. Walsh SW. Obesity: a risk factor for preeclampsia. Trends Endocrinol Metab. 2007; 18:365-370.
8. O'Brien TE, Ray JG, Chan WS. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology. 2003; 14: 368-374.
9. Alberti KM, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition: a consensus statement from the International Diabetes Federation. Diabet Med. 2006;23:469-480.
10. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974.
11. Ray JG, Vermeulen MJ, Schull MJ, Redelmeier DA. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet. 2005;366:1797-1803.
12. Irgens HU, Reisater L, Irgens LM, Lie RT, Roberts JM. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ. 2001;323:1213-1217.
13. Smith GCS, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129, 290 births. Lancet. 2001;357:2002-2006.
14. Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P, Smith WCS. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ. 2003;326:845.
15. Hannaford P, Ferry S, Hirsch S. Cardiovascular sequelae of toxaemia of pregnancy. Heart. 1997;77:154-158.
16. Kestenbaum B, Seliger SL, Easterling TR, Gillen DL, Critchlow CW, Stehman-Breen CO, Schwartz SM. Cardiovascular and thromboembolic events following hypertensive pregnancy. Am J Kidney Dis. 2003;42: 982-989.
17. Callaway LK, Lawlor DA, O'Callaghan M, Williams GM, Najman JM, Mclntyre HD. Diabetes mellitus in the 21 years after a pregnancy that was complicated by hypertension: findings from a prospective cohort study. Am J Obstet Gynecol. 2007;197:492.el-492.e7.
18. Funai EF, Friedlander Y, Paltiel O, Tíram E, Xue X, Deutsch L, Harlap S. Long-term mortality after preeclampsia. Epidemiology. 2005;16: 206-215.
19. Wikstrom A-K, Haglund B, Olovsson M, Lindeberg SN. The risk of maternal ischaemic heart disease after gestational hypertensive disease. BJOG. 2005;112:1486-1491.
20. Andersen TF, Madsen M, J0rgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register: a valuable source of data for modern health sciences. Dan Med Bull. 1999;46:263-268.
21. Klemmensen AK, Olsen SF, Osterdal ML, Tabor A. Validity of preeclampsia-related diagnoses recorded in a national hospital registry and in a postpartum interview of the women. Am J Epidemiol. 2007;166: 117-124.
22. Kristensen J, Langhoff-Roos J, Skovgaard LT, Kristensen FB. Validation of the Danish Birth Registration. J Clin Epidemiol. 1996;49:893-897.
23. Marsal K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B. Intra-uterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr. 1996;85:843-848.
24. Laivuori H, Tikkanen MJ, Ylikorkala 0. Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab. 1996;81: 2908-2911.
25. Pouta A, Hartikainen A-L, Sovio U, Gissler M, Laitinen J, McCarthy MI, Ruokonen A, Elliott P, Jarvelin M-R. Manifestations of metabolic syndrome after hypertensive pregnancy. Hypertension. 2004;43: 825-831.
26. Forest J-C, Girouard J, Masse J, Moutquin J-M, Kharfi A, Ness RB, Roberts JM, Giguere Y. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet Gynecol. 2005;105:1373-1380.
27. van Walraven C, Mamdani M, Cohn A, Katib Y, Walker M, Rodger MA. Research pointers: risk of subsequent thromboembolism for patients with pre-eclampsia. BMJ. 2003;326:791-792.
28. Ay C, Tengler T, Vormittag R, Simanek R, Dorda W, Vukovich T, Pabinger I. Venous thromboembolism a manifestation of the metabolic syndrome. Haematologica. 2007;92:374-380.
29. Ageno W, Prandoni P, Romualdi E, Ghirarduzzi A, Dentali F, Pesavento R, Crowther M, Venco A. The metabolic syndrome and the risk of venous thrombosis: a case-control study. J Thromb Haemost. 2006;4:1914-1918.
30. Pabinger I, Grafenhofer H, Kaider A, Ilic A, Eichinger S, Quehenberger P, Husslein P, Mannhalter C, Lechner K. Preeclampsia and fetal loss in women with a history of venous thromboembolism. Arterioscler Thromb Vasc Biol. 2001;21:874-879.
31. Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium-a register-based case-control study. Am J Obstet Gynecol. 2008;198:233.e231-233.e237.
32. Lindqvist P, Dahlback B, Marsal K. Thrombotic risk during pregnancy: a population study. Obstet Gynecol. 1999:94:595-599.
33. Kupferminc MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med. 1999;340:9-13.
34. Redman CWG, Sargent IL. Circulating microparticles in normal pregnancy and pre-eclampsia. Placenta. 2008;29:73-77.
35. Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, Dignat-George F, Freyssinet JM. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vase Biol. 2006;26: 2594-2604.
36. Vatten LJ, Skjaerven R. Is pre-eclampsia more than one disease? BJOG. 2004:111:298-302.
37. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol. 1998;179:1359-1375.
38. Krarup L-H, Boysen G, Janjua H, Prescott E, Truelsen T. Validity of stroke diagnoses in a National Register of Patients. Neuroepidemiology. 2007;28:150-154.
39. Kristensen JK, Drivsholm TB, Carstensen B, Steding-Jensen M, Green A. Validation of methods to identify known diabetes on the basis of health registers. Ugeskr Laeg. 2007;169:1687-1692.
40. Brown DW, Dueker N, Jamieson DJ, Cole JW, Wozniak MA, Stern BJ, Giles WH, Kittner SJ. Preeclampsia and the risk of ischemic stroke among young women: results from the stroke prevention in young women study. Stroke. 2006;37:1055-1059.
41. Solomon CG, Seely EW. Brief review: hypertension in pregnancy: a manifestation of the insulin resistance syndrome? Hypertension. 2001;37: 232-239.
42. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. Lancet. 1997;349:1202-1209.